FINNENCE ▪ THE WIRE FILE
THE WIRE · № 72603
News▲ Bullish
Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 08:00 UTC
LAST UPDATE2026-10-09 08:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Superior Phase 3 efficacy data supports a potential best-in-class oral PDE4 inhibitor.
Strong psoriasis data boosts PDE4 program
CATALYST TO WATCH
Regulatory filing or partnership news
MAIN RISK
Press release may overstate clinical significance
FULL DISPATCH
In a head-to-head Phase 3 trial, prifemilast nearly doubled the rate of PASI 75 response compared with apremilast and achieved superiority on both co-primary endpoints Results support the potential of prifemilast to deliver greater efficacy than apremilast, with low rates of serious...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Healthcare
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development2026-10-09 02:13 UTC
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development2026-10-09 02:13 UTC
←CORRELATIONshares Healthcare
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 20262026-10-09 02:48 UTC
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 20262026-10-09 02:48 UTC
←CORRELATIONshares Healthcare
Cantourage and Green Karat deepen strategic partnership following EU-GMP certification2026-10-09 06:47 UTC
Cantourage and Green Karat deepen strategic partnership following EU-GMP certification2026-10-09 06:47 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.